Business, Energy and Industrial Strategy Committee

Debate between Rachel Reeves and Peter Kyle

Thursday 17th May 2018 Commons Chamber

[Rachel Reeves]

We already export to countries outside the European Union. We are a success in that sector. We took huge amounts of evidence in the UK and in Brussels from small and big businesses, and not a single one pointed to any benefits of leaving the EU, or any opportunities we could seize that we do not have today.

[Peter Kyle (Hove) (Lab)]

The report says that regulatory divergence will cost jobs and investment, and will make certain medicines more difficult to obtain in this country. Is that correct?

[Rachel Reeves]

I can say to my hon. Friend—who sat in on the evidence sessions with me—that there are a number of issues, which I hope I put across in my statement. Some medicines lose their benefit quickly, and if there are big delays at the border, they will not have the effect that they would have had if they had reached patients quickly. That is one risk. Another is tariffs, which could also be a huge issue. Although WTO rules specify that medicines are tariff-free, they have not been updated for eight years, so many medicines are not included. Currently, medicines that are tested in any country in the European Union can then be accessed in the UK, but that may not be the case after we leave the European Union. For those three reasons, I think that there is a risk to patients from a hard Brexit, at least, or from a no-deal scenario.

Domestic Gas and Electricity (Tariff Cap) Bill

Debate between Rachel Reeves and Peter Kyle

2nd reading: House of Commons
Tuesday 6th March 2018 Commons Chamber

[Rachel Reeves]

I hope that does not happen. Ofgem and the Competition and Markets Authority are putting the cap in place to make it easier for customers to switch. Northern Ireland, where there is a price cap, has as much switching as we do. The international examples suggest that we can have switching in a market that also has a price cap.

[Peter Kyle]

Will my hon. Friend give way?

[Rachel Reeves]

Sorry, I am not going to give way again, otherwise I am going to get into trouble with Madam Deputy Speaker, and I am more scared of her than I am of my hon. Friend.

[Peter Kyle]

For the time being.

[Rachel Reeves]

Indeed.

There are two areas where the Government need to take action to ensure that, once the price cap is over in 2021 or 2023, we do not go back to business as usual. First, they need to give greater clarity about what will happen to things such as the energy company obligation and the warm home discount once the price cap goes away.

Secondly, I welcome the Secretary of State’s commitment today that the statutory instrument on data sharing to allow energy companies to know who their vulnerable customers are will be tabled before the Bill receives Royal Assent. We need to see that SI and those changes, because the energy companies do not know all the customers who are vulnerable and experiencing financial difficulties. Our Committee is convinced that those two issues will be key in ensuring that, both during and after implementation of the price cap, those who need it most get the protection they need.

The time for action is over-ripe. These rip-off practices cannot be allowed to continue. There is cross-party support for this legislation, and both the Labour and Conservative manifestos at the last election included a commitment to cap energy prices. Now the Government must make that cap a reality before next winter. I strongly urge colleagues across the House to support the Bill, to deliver some fairness to all our constituents.